KL

Ketan Lalit Shah

Active Director Director DIN 00083326
DIN 00083326 First appointment Jun 1991 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 3 historical roles
Total affiliations 9 Since Jun 1991
Shareholding value •••• Premium profile

About Ketan Lalit Shah

Data last updated:

Ketan Lalit Shah has 35 years in corporate governance. Holds Director and Designated Partner roles. Currently with 6 companies, including Chaitanya Life Science Private Limited and Anuh Pharma Limited. Formerly with 3 companies, such as Plutonium Business Solution Private Limited and Pharmarack Technologies Private Limited. Engaged in General Business, Technology. The 4 current companies with reported revenue have a combined latest revenue of ₹1,453 Cr; the largest is Eskay Iodine Private Limited at ₹741 Cr (FY 2025).

DIN 00083326
Primary Designation Director
First Appointment 29 Jun 1991
Oldest Company Age 79 yrs
Largest company Eskay Iodine Private Limited · ₹741 Cr (FY 2025)
Combined revenue ₹1,453 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eskay Iodine Private Limited U24100MH2011PTC221911
Director13 Sep 20112011₹741 Cr (FY 2025)Active
Anuh Pharma Limited L24230MH1960PLC011586
Director09 Aug 20161960₹671 Cr (FY 2025)Active
Malabar Hill Club Limited U34300MH1947GAP005941
Director21 Dec 20151947₹26.68 Cr (FY 2025)Active
Director01 Jun 20212010₹13.59 Cr (FY 2024)Active
Skites India Llp AAF-4097
Designated Partner30 Dec 20152015–Active
Designated Partner31 Mar 20152015–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Mar 19961983₹85.48 Cr (FY 2025)Active
Director30 Sep 20162015₹45.34 Cr (FY 2024)Active
L P Shah Holdings And Trades Pvt Ltd U67120MH1983PTC029949
Director29 Jun 19911983–Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chaitanya Life Science Private Limited
Anuh Pharma Limited
Malabar Hill Club Limited
L P Shah Holdings And Trades Pvt Ltd
Premium access

Shareholding and investment profile for Ketan Lalit Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ketan Lalit Shah

Ketan Lalit Shah has 35 years in corporate governance. Holds Director and Designated Partner roles. Currently with 6 companies, including Chaitanya Life Science Private Limited and Anuh Pharma Limited. Formerly with 3 companies, such as Plutonium Business Solution Private Limited and Pharmarack Technologies Private Limited. Engaged in General Business, Technology. The 4 current companies with reported revenue have a combined latest revenue of ₹1,453 Cr; the largest is Eskay Iodine Private Limited at ₹741 Cr (FY 2025).

Ketan Lalit Shah is associated with 6 companies as Director and Designated Partner, including Eskay Iodine Private Limited (₹741 Cr), Anuh Pharma Limited (₹671 Cr), Malabar Hill Club Limited (₹26.68 Cr).

Ketan Lalit Shah has expertise in General Business, Technology.

Ketan Lalit Shah has 35 years in corporate governance.

By reported revenue, the largest current company of Ketan Lalit Shah is Eskay Iodine Private Limited, with revenue of ₹741 Cr (FY 2025).

The 4 current companies of Ketan Lalit Shah that report revenue have a combined latest revenue of ₹1,453 Cr.

Ketan Lalit Shah currently holds positions at 6 companies; the 5 largest by reported revenue are Eskay Iodine Private Limited (₹741 Cr), Anuh Pharma Limited (₹671 Cr), Malabar Hill Club Limited (₹26.68 Cr), Chaitanya Life Science Private Limited (₹13.59 Cr), Skites India Llp.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available